Purple Biotech (NASDAQ:PPBT) Raised to Hold at Zacks Research
Purple Biotech (NASDAQ:PPBT – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports. Other equities research analysts have also recently issued research reports about the stock. HC Wainwright dropped their price target on shares of Purple Biotech [...]